Proactive High-Dose IV Iron Is Preferred Therapy in ESKD Patients: CON.

Abhijit V KshirsagarXiaojuan Li

Published in: Kidney360 (2021)

Keyphrases

high dose
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
low dose
prognostic factors
stem cells
patient reported